Fortress Biotech (FBIO) Financial Statements & Analysis

Fortress Biotech (FBIO) Income Statement

Fortress Biotech reported revenue of $63.26M in fiscal 2025 (fiscal year ended Mar 31, 2026), up 9.7% from $57.67M a year earlier. Net income was $6.82M, a net margin of 10.8%. Gross margin was 66.9% and operating margin -111.0%. In the most recent quarter, Q2 fiscal 2026 (ended Jun 30, 2026), revenue was $18.72M, up 14.0% from the same quarter a year earlier.

Fortress Biotech Income Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Fortress Biotech, Inc. income statement - Annual data in millions USD
Breakdown	FY 2025	FY 2025	FY 2024	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Mar 2026	Dec 2025	Mar 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Mar 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Revenue & Gross Profit
Revenue	63.26	63.26	57.68	57.68	84.51	75.74	68.79	45.60	45.60	36.63	26.88	187.58
Cost of Revenue	20.92	20.92	20.88	20.88	22.89	30.78	160.95	14.59	78.70	10.53	6.13	161.20
Gross Profit	42.34	42.34	36.80	36.80	61.62	44.97	36.71	31.01	-33.10	26.10	20.76	26.38
Operating Expenses
Research & Development	11.90	11.90	56.88	56.88	106.07	134.88	128.87	64.11	-	81.33	87.38	52.49
Selling, General & Administrative	96.40	96.40	87.73	87.73	90.98	113.66	86.84	61.17	61.17	55.59	53.37	73.02
Operating Expenses	112.56	112.56	147.18	148.04	200.82	248.53	225.25	125.28	61.17	136.92	140.75	127.59
Operating Income	-70.22	-70.22	-110.38	-111.24	-139.20	-203.56	-188.54	-94.27	-94.27	-110.82	-120.00	-89.80
Other Income/Expense
Interest Income	2.49	2.49	2.68	2.68	3.00	1.40	0.65	1.52	1.52	2.56	1.10	0.82
Interest Expense	8.71	8.71	9.93	11.59	11.92	10.42	-15.31	15.33	-15.33	11.85	10.34	7.69
Other Income/Expense	36.69	44.31	-10.16	1.54	-2.12	2.34	24.19	-8.58	-1.19	9.16	-10.80	-7.72
Income
Income Before Tax	-33.54	-33.54	-120.54	-120.54	-153.63	-213.46	-164.35	-102.85	-102.85	-101.66	-130.80	-98.32
Income Tax Expense	-0.62	-0.62	0.31	0.31	0.52	0.45	0.47	0.14	0.14	0.00	-0.46	1.51
Net Income	6.82	6.82	-46.00	-46.00	-60.64	-86.58	-64.70	-46.53	-46.53	-39.96	-84.15	-66.88
Net Income - Continuous Operations	6.82	-32.92	-46.00	-120.86	-154.15	-213.91	-164.83	-46.53	-	-39.96	-84.15	-66.88
Net Income - Discontinued Operations	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-20.17	-20.17	-104.49	-104.49	-135.72	-193.69	-173.90	-87.82	-90.57	-88.48	-118.40	-88.57
EBIT	-	-24.83	-	-108.96	-141.72	-203.05	-179.00	-	-94.27	-	-	-
Depreciation & Amortization	4.66	4.26	4.46	3.42	3.77	9.35	5.10	5.33	3.70	4.65	2.06	1.26
Earnings Per Share
Basic EPS	-	-	-3.00	-3.00	-8.00	-15.00	-12.00	-10.00	-10.00	-11.00	-29.00	-24.00
Diluted EPS	-	-	-3.00	-3.00	-8.00	-15.00	-12.00	-10.00	-10.00	-11.00	-29.00	-24.00
Basic Shares Outstanding	27.90	27.90	20.78	20.78	8.11	5.92	5.45	4.80	4.80	3.65	2.90	2.78
Diluted Shares Outstanding	35.76	27.90	20.78	20.78	8.11	5.92	5.45	4.80	4.80	3.65	2.90	2.78

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Fortress Biotech Financial Statements

What was Fortress Biotech's revenue in fiscal 2025?

Fortress Biotech reported revenue of $63.26M in fiscal 2025 (fiscal year ended Mar 31, 2026). That was up 9.7% from $57.67M a year earlier.

Is Fortress Biotech profitable?

Yes. Fortress Biotech earned net income of $6.82M in fiscal 2025, a net margin of 10.8%. In fiscal 2024 it lost $46.00M.

What is Fortress Biotech's operating margin?

Fortress Biotech's operating income was −$70.22M on revenue of $63.26M in fiscal 2025, an operating margin of -111.0%, compared with -191.4% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition